Chris Worth
Overview
Explore the profile of Chris Worth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Worth C, Auckburally S, Worthington S, Ahmad S, OShea E, Senniappan S, et al.
J Diabetes Sci Technol
. 2024 Nov;
:19322968241255842.
PMID: 39564699
Background: The glycemic characterization of congenital hyperinsulinism (HI), a rare disease causing severe hypoglycemia in childhood, is incomplete. Continuous glucose monitoring (CGM) offers deep glycemic phenotyping to understand disease burden...
2.
Klonoff D, Freckmann G, Pleus S, Kovatchev B, Kerr D, Tse C, et al.
J Diabetes Sci Technol
. 2024 Oct;
18(6):1346-1361.
PMID: 39369312
Introduction: An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value...
3.
Worth C, Gokul P, Ramsden K, Worthington S, Salomon-Estebanez M, Maniyar A, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1338980.
PMID: 38616820
Introduction: Neonatal and early-life hypoglycaemia, is a frequent finding but is often non-specific and asymptomatic, making detection and diagnosis challenging. Hypoglycaemia-induced cerebral injury can be identified by magnetic resonance imaging...
4.
Worth C, Worthington S, Auckburally S, OShea E, Ahmad S, Fullwood C, et al.
J Diabetes Sci Technol
. 2024 Apr;
:19322968241245923.
PMID: 38616550
Introduction: Patients with congenital hyperinsulinism (HI) require constant glucose monitoring to detect and treat recurrent and severe hypoglycemia. Historically, this has been achieved with intermittent self-monitoring blood glucose (SMBG), but...
5.
Estebanez M, Worth C, Banerjee I
Indian Pediatr
. 2024 Apr;
61(6):578-584.
PMID: 38584412
Congenital hyperinsulinism (CHI) is a rare condition but is a common cause of severe and persistent hypoglycemia in early life. Prompt recognition of CHI is critical to prevent the impact...
6.
Shaikh M, Lucas-Herald A, Dastamani A, Estebanez M, Senniappan S, Abid N, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1231043.
PMID: 38027197
Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent hypoglycaemia in infants and young children caused by inappropriate insulin over-secretion. CHI is of heterogeneous aetiology with a significant...
7.
Worth C, Nutter P, Salomon-Estebanez M, Auckburally S, Dunne M, Banerjee I, et al.
Digit Health
. 2023 Aug;
9:20552076231192011.
PMID: 37545627
Background: Children with hypoglycaemia disorders, such as congenital hyperinsulinism (CHI), are at constant risk of hypoglycaemia (low blood sugars) with the attendant risk of brain injury. Current approaches to hypoglycaemia...
8.
Stokes H, Jones J, Worth C, Nicholson J, Fullwood C, Banerjee I
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1167854.
PMID: 37324260
Introduction: Easypod-connect™ for childhood growth disorders is a unique connected system that enables transmission of injection adherence information for recombinant human growth hormone (r-hGH). Although this system has the potential...
9.
Worth C, Hoskyns L, Salomon-Estebanez M, Nutter P, Harper S, Derks T, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1116864.
PMID: 36755920
In 2023, childhood hypoglycaemia remains a major public health problem and significant risk factor for consequent adverse neurodevelopment. Irrespective of the underlying cause, key elements of clinical management include the...
10.
Worth C, Dunne M, Salomon-Estebanez M, Harper S, Nutter P, Dastamani A, et al.
Front Endocrinol (Lausanne)
. 2022 Nov;
13:1016072.
PMID: 36407313
Objective: Continuous Glucose Monitoring (CGM) is gaining in popularity for patients with paediatric hypoglycaemia disorders such as Congenital Hyperinsulinism (CHI), but no standard measures of accuracy or associated clinical risk...